Clinical Outcomes of Radiologic Relapse in Patients With Cardiac Sarcoidosis Under Immunosuppressive Therapies

This publication has 19 references indexed in Scilit:

• Cardiac Sarcoidosis
  Circulation, 2015
• Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis
  Heart, 2014
• Atrioventricular Block as the Initial Manifestation of Cardiac Sarcoidosis in Middle‐Aged Adults
  Journal of Cardiovascular Electrophysiology, 2014
• Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology Recommendations
  Annals of Nuclear Medicine, 2014
• Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis
  Current Opinion in Pulmonary Medicine, 2013
• Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
  Journal of the American Society of Echocardiography, 2005
• Recurrence of Cardiac Sarcoidosis in a Heart Transplant Recipient
  The Journal of Heart and Lung Transplantation, 2005
• Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis†
  European Heart Journal, 2005
• Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis
  The American Journal of Cardiology, 2005
• Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device
  JACC, 1991